
1. nihon yakurigaku zasshi. 2015 sep;146(3):159-70. doi: 10.1254/fpj.146.159.

[preclinical clinical properties vaniprevir (vanihep® capsules 150 mg), 
novel therapeutic agent hepatitis c].

[article japanese]

kinoshita k, iwasa t, takase a, nakamura k.

doi: 10.1254/fpj.146.159 
pmid: 26354016  [indexed medline]

